Fibrocell Science announces positive results from iPS cells study

Fibrocell Science, Inc., a biotechnology company, has announced positive results from a study demonstrating a potential mechanism for converting research-grade adult skin cells into clinical grade induced pluripotent stem, or iPS, cells.

http://technews.tmcnet.com/news/2013/08/30/7377861.htm